# Peter Charles Klatsky, M.D., Inc. – FDA Inspection, Apr 11, 2022

Source: https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/daa53203-eefe-4220-b8bf-54b47dca07f2
Source feed: FDA_Inspections

> FDA inspection 1167160 of Peter Charles Klatsky, M.D., Inc., April 11, 2022. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167160
- Company Name: Peter Charles Klatsky, M.D., Inc.
- Inspection Date: 2022-04-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1270885 - 2025-05-16

Company: https://www.keypedia.com/companies/peter-charles-klatsky-md-inc/e51be983-ee3f-46e6-8d32-f8e9c720ba63

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d